Skip to main content

Table 2 Differences of coagulation parameters in cancer and control groups

From: Coagulation parameters for the differential diagnosis of pancreatic cancer in the early stage: a retrospective study

 

PC

BPD

P

EPC

BPD

P

Median (Mean)

Q1–Q3 (SD)

Median (Mean)

Q1–Q3 (SD)

Median (Mean)

Q1–Q3 (SD)

Median (Mean)

Q1–Q3 (SD)

PT(s)

11.90

11.48–12.33

11.70

11.30–12.30

0.393

11.70

11.30–12.20

11.70

11.30–12.30

0.656

APTT(s)

27.19

2.59

28.25

2.86

0.001

26.97

2.67

28.25

2.86

0.000

FIB(g/L)

3.395

2.92–4.29

2.61

2.21–3.44

0.000

3.33

2.70–4.31

2.61

2.21–3.44

0.000

TT(s)

17.30

16.68–18.1

17.7

16.78–18.30

0.059

17.50

16.80–18.10

17.7

16.78–18.30

0.354

DD2(mg/L)

0.49

0.29–0.85

0.315

0.19–0.58

0.000

0.44

0.28–0.74

0.315

0.19–0.58

0.005

PLT(10^9/L)

186.00

144.75–236.00

195.50

156.00–232.00

0.352

187.50

148.00–238.25

195.50

156.00–232.00

0.496

R(min)

5.10

4.50–6.10

5.40

4.80–6.20

0.047

5.00

4.40–6.13

5.40

4.80–6.20

0.047

K(min)

1.70

1.20–2.20

1.80

1.60–2.20

0.003

1.65

1.30–2.20

1.80

1.60–2.20

0.010

Angle(deg)

67.30

62.0–71.75

65.60

60.50–68.33

0.002

67.55

61.95–71.48

65.60

60.50–68.33

0.007

MA(mm)

63.70

58.58–67.53

61.55

58.13–64.43

0.009

63.75

58.38–67.50

61.55

58.13–64.43

0.025

CI

1.10

− 0.50–2.20

0.40

− 0.83–1.40

0.002

1.05

− 0.43–2.13

0.40

− 0.83–1.40

0.006

Ly30(%)

0.00

0.00–0.70

0.00

0.00–0.20

0.012

0.00

0.00–0.73

0.00

0.00–0.20

0.058

  1. PC represents pancreatic cancer, EPC represents early stage pancreatic cancer, BPD represents benign pancreatic disease. The continuous data with non-normal distribution has been presented as median (Q1–Q3), whereas continuous data with normal distribution has been presented as mean ± SD